Dyadic International Inc., DE

-0.14 (-4.44%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)85.08M
Current PEN/A
Forward PE N/A
2yr Forward PE 100.33
See more stats
Estimates Current Quarter
Revenue$2.72 Million
Adjusted EPS-$0.06
See more estimates
10-Day MA$2.98
50-Day MA$2.44
200-Day MA$3.62
See more pivots

Dyadic International Inc., DE Stock, NASDAQ:DYAI

140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477-5094
United States of America
Phone: +1.561.743.8333
Number of Employees: 7


Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.